findmyKOL
Clinical trialNCT01266460CompletedPhase 2Interventional

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

SponsorGynecologic Oncology GroupEnrollment54Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham Cancer Center

    Birmingham, Alabama, United States

  • Saint Joseph'S Hospital and Medical Center

    Phoenix, Arizona, United States

  • Uc San Diego Moores Cancer Center

    La Jolla, California, United States

  • Los Angeles County-Usc Medical Center

    Los Angeles, California, United States

  • Usc / Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Ucsf Medical Center-Mission Bay

    San Francisco, California, United States

  • Ucsf Medical Center-Mount Zion

    San Francisco, California, United States

  • Memorial Health University Medical Center

    Savannah, Georgia, United States

  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

  • Sinai Hospital of Baltimore

    Baltimore, Maryland, United States

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Montefiore Medical Center-Einstein Campus

    The Bronx, New York, United States

  • Carolinas Medical Center/levine Cancer Institute

    Charlotte, North Carolina, United States

  • Case Western Reserve University

    Cleveland, Ohio, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • Uh Seidman Cancer Center at Lake Health Mentor Campus

    Mentor, Ohio, United States

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma, United States

  • Oklahoma Cancer Specialists and Research Institute-Tulsa

    Tulsa, Oklahoma, United States

  • Ut Southwestern/simmons Cancer Center-Dallas

    Dallas, Texas, United States

  • University of Texas Medical Branch

    Galveston, Texas, United States

  • Virginia Commonwealth University/massey Cancer Center

    Richmond, Virginia, United States

  • Froedtert and the Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 May 2011
Primary completion
2 Oct 2018
Completion
2 Oct 2018
Last update posted
11 Sept 2020
Registered enrollment
54
Registry id
NCT01266460

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.